Kin Pan Au, See Ching Chan, Kenneth Siu Ho Chok, Albert Chi Yan Chan, Tiffany Cho Lam Wong, William Wei Sharr, Chung Mau Lo – 29 June 2015 – Our aim was to study the long‐term outcomes of living donor liver transplantation using small‐for‐size (SFS) grafts. From July 2002 to July 2009, 233 patients received a right liver graft with a middle hepatic vein from a living donor in our center.
Russell H. Wiesner – 29 June 2015
John B. Seal, Markus Selzner, George Loss – 29 June 2015
Sanjay Govil, Naresh P. Shanmugam, Mettu S. Reddy, Gomathy Narasimhan, Mohamed Rela – 29 June 2015
Phillip Hylemon, Masayuki Nagahashi, Kazuaki Takabe, Huiping Zhou – 29 June 2015
Marcello Tavio, Marco Vivarelli, Stefano Menzo, Andrea Gori, Paolo Antonio Grossi, Anna Marigliano – 29 June 2015
John Y.L. Chiang – 29 June 2015
Jean‐Michel Pawlotsky, Robert Flisiak, Shiv K. Sarin, Jens Rasenack, Teerha Piratvisuth, Wan‐Long Chuang, Cheng‐Yuan Peng, Graham R. Foster, Samir Shah, Heiner Wedemeyer, Christophe Hézode, Wei Zhang, Kelly A. Wong, Bin Li, Claudio Avila, Nikolai V. Naoumov, on behalf of the VITAL‐1 study team – 27 June 2015 – Alisporivir is a cyclophilin inhibitor with pan‐genotypic anti–hepatitis C virus (HCV) activity and a high barrier to viral resistance. The VITAL‐1 study assessed alisporivir as interferon (IFN)‐free therapy in treatment‐naïve patients infected with HCV genotype 2 or 3.
Peipei Lu, Wen Xie – 25 June 2015
AASLD/IDSA HCV Guidance Panel – 25 June 2015